{
  "id": "Brescia_COVID_Respiratory_Severity_Scale_BCRSS_Algorithm_guideline.v1",
  "gdl_version": "2.0",
  "concept": "gt0001",
  "language": {
    "original_language": "ISO_639-1::en"
  },
  "description": {
    "original_author": {
      "date": "2020-09-04",
      "name": " Maryam Razavi",
      "organisation": "@CambioCDS",
      "email": "maryam.razavi@cambio.se"
    },
    "lifecycle_state": "Author draft",
    "details": {
      "en": {
        "id": "en",
        "purpose": "To assess and provide treatment recommendations in patients with confirmed/presumed COVID-19 pneumonia. ",
        "keywords": [
          "Respiratory",
          "COVID",
          "COVID-19"
        ],
        "use": "Use to recommend increasing treatment recommendations, simplify the clinical summary of a patient’s status, compare patients to one another, monitor patients nearing a critical action point more closely, and trend patients’ levels over time.\n\nUse in patients who have COVID-19 pneumonia OR have had COVID-19 symptoms for ≥7 days AND are either PCR+ OR high clinical suspicion for COVID-19.\nIPrecondition: [Patient has COVID-19 pneumonia or COVID-19 symptoms for ≥7 days] AND [Patient is PCR+ OR high suspicion for COVID-19/PCR pending]. \nTesting Criteria: \n- Patient wheezing OR unable to speak in full sentences while at rest/with minimal effort: yes=1, No=0.\n- Respiratory rate >22: yes=1, No=0.\n- PaO2 <65 mmHg or SpO2 <90%: yes=1, No=0.\n- Repeat CXR is significantly worsening: yes=1, No=0.\nWhen >2 criteria are selected, the algorithm recommends escalating to non-invasive ventilation (NIV/CPAP/BiPAP) or high-flow nasal cannula (HFNC) and then reassessing patient criteria. \nDoes the patient still have >2 criteria despite NIV/HFNC?: No, Yes. \nIntubation recommended for worsening symptoms despite NIV/HFNC.\nWith the patient intubated:\nIs the intubated patient on CMV? : No, Yes.\nPaO2/FiO2 <150 mmHg : No, Yes.\nPatient on neuromuscular blockade (NMBA): No, Yes.\nPatient prone or on ECMO: No, Yes.\nInterpretation: \nThe formula of testing criteria score: Additional of selected parameters. \nTesting criteria score equal to 0= Level 0, Management: Keep patient monitored with pulse oximetry and clinical evaluation, Medications: Lopinavir/ritonavir.\nTesting criteria score equal 1=Level 1, Management: Provide supplemental O2. Keep the patient monitored with pulse oximetry and clinical evaluation, Medications: Lopinavir/ritonavir.\nTesting criteria score equal to 2= Level 2, Management: Perform CXR and ABG. Provide supplemental O2. Keep the patient monitored with pulse oximetry and clinical evaluation, Medications: Lopinavir/ritonavir. Consider dexamethasone, Consider age/comorbidities, cognitive decline.\nTesting criteria score equal to 3= Level 3, Management: Trial of non-invasive ventilation (CPAP/BiPAP), or high-flow nasal cannula (HFNC) recommended. If the above clinical criteria worsening or the patient clinically worsening despite this trial, intubation recommended. Otherwise, perform CXR every 2 days and ABG twice a day, Medications: Lopinavir/ritonavir. Consider dexamethasone and consider starting tocilizumab. Consider age/comorbidities, cognitive decline. Inclusion criteria.\n\nWhen Testing criteria score >2 and Does the patient still have >2 criteria despite NIV/HFNC? =No: Re-select the number of criteria present and follow management.\n\nWhen Testing criteria score >2, and Does the patient still have >2 criteria despite NIV/HFNC? Yes: \n-\t Intubation recommended for worsening symptoms despite NIV/HFNC. With the patient intubated:\nIs the intubated patient on CMV?: No= Level 4, Management: Follow ICU protocols; use local ventilator weaning protocol, Medications: Remdesivir (if not available, lopinavir/ritonavir) PLUS considering dexamethasone and tocilizumab, Consider age/comorbidities, cognitive decline, Inclusion criteria.\nIs the intubated patient on CMV? Yes and PaO2/FiO2 <150 mmHg: No= Level 5, Management: Try to minimize sedation (RASS -1 to 0). Perform SBT daily, Medications: Remdesivir (if not available, lopinavir/ritonavir) PLUS considering dexamethasone and tocilizumab, Consider age/comorbidities, cognitive decline, Inclusion criteria.\nDoes the patient still have >2 criteria despite NIV/HFNC? Yes and Is the intubated patient on CMV? Yes and PaO2/FiO2 <150 mmHg: Yes and Patient on neuromuscular blockade (NMBA): No= Level 6, Management: Try to minimize sedation (RASS -1 to 0), Medications: Remdesivir (if not available, lopinavir/ritonavir) PLUS considering dexamethasone and tocilizumab, consider age/comorbidities, cognitive decline, Inclusion criteria.\nDoes the patient still have >2 criteria despite NIV/HFNC?: Yes and Is the intubated patient on CMV?: Yes and PaO2/FiO2 <150 mmHg: Yes and Patient on neuromuscular blockade (NMBA): Yes, Patient prone or on ECMO: No= Level 7, Management: Perform best PEEP and Compliance calculation. Try to suspend NMBA. Optimize volume status, Medications: Remdesivir (if not available, lopinavir/ritonavir) PLUS considering dexamethasone and tocilizumab, consider age/comorbidities, cognitive decline, Inclusion criteria.\n\nDoes the patient still have >2 criteria despite NIV/HFNC?: Yes and Is the intubated patient on CMV?: Yes and PaO2/FiO2 <150 mmHg: Yes and Patient on neuromuscular blockade (NMBA): Yes, Patient prone or on ECMO: Yes= Level 8, Management: Extreme level of medical complexity given failing other management options; defer to clinician expertise, Medications: Remdesivir (if not available, lopinavir/ritonavir) PLUS considering dexamethasone and tocilizumab, consider age/comorbidities, cognitive decline, Inclusion criteria.\nInclusion criteria for tocilizumab:\nEnd of the initial phase of high viral load of COVID-19 (e.g. apyretic from >72h and/or elapsed ≥7 days after the onset of symptoms).\nWorsening of respiratory exchanges, such as to require non-invasive or invasive support from ventilation (Level ≥3).\nHigh levels of IL-6 (>40 pg/mL); alternatively, high levels of d-dimer, CRP, ferritin, and/or fibrinogen progressively increasing.\n\nUse with caution; this is being used in Italy for assessment, trending, and treatment recommendations and it was launched during the COVID-19 crisis. Not externally validated. \n",
        "misuse": "",
        "copyright": "@CambioCDS"
      }
    },
    "other_details": {
      "references": "1. Italian Society of Infectious and Tropical Diseases (SIMIT). Guidelines on therapeutic and supportive management for patients with COVID-19 coronavirus infection. 2020."
    }
  },
  "definition": {
    "data_bindings": {
      "gt0002": {
        "id": "gt0002",
        "model_id": "openEHR-EHR-OBSERVATION.brescia_covid_respiratory_severity_scale_bcrss_algorithm.v0",
        "template_id": "openEHR-EHR-OBSERVATION.brescia_covid_respiratory_severity_scale_bcrss_algorithm.v0",
        "type": "INPUT",
        "elements": {
          "gt0003": {
            "id": "gt0003",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0007]/items[at0004]"
          },
          "gt0004": {
            "id": "gt0004",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0007]/items[at0008]"
          },
          "gt0005": {
            "id": "gt0005",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0007]/items[at0011]"
          },
          "gt0006": {
            "id": "gt0006",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0007]/items[at0014]"
          },
          "gt0007": {
            "id": "gt0007",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0029]/items[at0017]"
          },
          "gt0008": {
            "id": "gt0008",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0029]/items[at0020]"
          },
          "gt0009": {
            "id": "gt0009",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0029]/items[at0023]"
          },
          "gt0010": {
            "id": "gt0010",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0029]/items[at0026]"
          },
          "gt0011": {
            "id": "gt0011",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0031]"
          },
          "gt0012": {
            "id": "gt0012",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0034]"
          },
          "gt0013": {
            "id": "gt0013",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0037]"
          },
          "gt0014": {
            "id": "gt0014",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0040]"
          },
          "gt0015": {
            "id": "gt0015",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0043]"
          }
        }
      },
      "gt0016": {
        "id": "gt0016",
        "model_id": "openEHR-EHR-OBSERVATION.brescia_covid_respiratory_severity_scale_bcrss_algorithm.v0",
        "template_id": "openEHR-EHR-OBSERVATION.brescia_covid_respiratory_severity_scale_bcrss_algorithm.v0",
        "type": "OUTPUT",
        "elements": {
          "gt0017": {
            "id": "gt0017",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0029]/items[at0054]"
          }
        }
      },
      "gt0018": {
        "id": "gt0018",
        "model_id": "openEHR-EHR-EVALUATION.brescia_covid_respiratory_severity_scale_bcrss_algorithm.v0",
        "template_id": "openEHR-EHR-EVALUATION.brescia_covid_respiratory_severity_scale_bcrss_algorithm.v0",
        "type": "OUTPUT",
        "elements": {
          "gt0019": {
            "id": "gt0019",
            "path": "/data[at0001]/items[at0002]"
          },
          "gt0020": {
            "id": "gt0020",
            "path": "/data[at0001]/items[at0003]"
          },
          "gt0021": {
            "id": "gt0021",
            "path": "/data[at0001]/items[at0004]"
          },
          "gt0022": {
            "id": "gt0022",
            "path": "/data[at0001]/items[at0005]"
          },
          "gt0023": {
            "id": "gt0023",
            "path": "/data[at0001]/items[at0006]"
          },
          "gt0036": {
            "id": "gt0036",
            "path": "/data[at0001]/items[at0008]"
          }
        }
      }
    },
    "pre_conditions": [
      "($gt0003|Patient has COVID-19 pneumonia|==local::at0005|Yes|)||($gt0004|COVID-19 symptoms for ≥7 days|==local::at0009|Yes|)",
      "($gt0005|Patient is PCR positive|==local::at0012|Yes|)||($gt0006|High suspicion for COVID-19/PCR pending|==local::at0015|Yes|)"
    ],
    "rules": {
      "gt0024": {
        "id": "gt0024",
        "priority": 11,
        "when": [
          "$gt0007|Patient wheezing OR unable to speak in full sentences while at rest/with minimal effort|!=null",
          "$gt0008|Respiratory rate >22|!=null",
          "$gt0009|PaO2 <65 mmHg or SpO2 <90%|!=null",
          "$gt0010|Repeat CXR is significantly worsening|!=null"
        ],
        "then": [
          "$gt0017|Tesing criteria score|.magnitude=$gt0007.value+$gt0008.value+$gt0009.value+$gt0010.value"
        ]
      },
      "gt0025": {
        "id": "gt0025",
        "priority": 10,
        "when": [
          "$gt0017|Tesing criteria score|==0"
        ],
        "then": [
          "$gt0019|Level|='0'",
          "$gt0020|Management|='Keep patient monitored with SpO2 (pulse oximetry) and clinical evaluation.'",
          "$gt0021|Medications|='Lopinavir/ Ritonavir.'"
        ]
      },
      "gt0026": {
        "id": "gt0026",
        "priority": 9,
        "when": [
          "$gt0017|Tesing criteria score|==1"
        ],
        "then": [
          "$gt0019|Level|='1'",
          "$gt0020|Management|='Provide supplemental O2. Keep patient monitored with SpO2 (pulse oximetry) and clinical evaluation.'",
          "$gt0021|Medications|='Lopinavir/ Ritonavir.'"
        ]
      },
      "gt0027": {
        "id": "gt0027",
        "priority": 8,
        "when": [
          "$gt0017|Tesing criteria score|==2"
        ],
        "then": [
          "$gt0019|Level|='2'",
          "$gt0020|Management|='Perform CXR and ABG. Provide supplemental O2. Keep patient monitored with pulse oximetry and clinical evaluation.'",
          "$gt0021|Medications|='Lopinavir/ritonavir. Consider dexamethasone'",
          "$gt0022|Medication consideration|=local::at0007|Consider age/comorbidities, cognitive decline.|"
        ]
      },
      "gt0028": {
        "id": "gt0028",
        "priority": 7,
        "when": [
          "$gt0017|Tesing criteria score|>=3"
        ],
        "then": [
          "$gt0019|Level|='3'",
          "$gt0020|Management|='Trial of non-invasive ventilation (CPAP/BiPAP) or high-flow nasal canula (HFNC) recommended. If above clinical criteria worsening or patient clinically worsening despite this trial, intubation recommended. Otherwise, perform CXR every 2 days and ABG twice a day.'",
          "$gt0021|Medications|='Lopinavir/ritonavir. Consider dexamethasone and consider starting Tocilizumab.'",
          "$gt0022|Medication consideration|=local::at0007|Consider age/comorbidities, cognitive decline.|",
          "$gt0023|Inclusion criteria for tocilizumab|='First, end of the initial phase of high viral load of COVID-19 (e.g. apyretic from >72h and/or elapsed ≥7 days after the onset of symptoms). Second, worsening of respiratory exchanges, such as to require non-invasive or invasive support from ventilation (Level ≥3). Third, High levels of IL-6 (>40 pg/mL); alternatively high levels of d-dimer, CRP, ferritin, and/or fibrinogen progressively increasing.'"
        ]
      },
      "gt0035": {
        "id": "gt0035",
        "priority": 6,
        "when": [
          "$gt0017|Tesing criteria score|>2",
          "$gt0011|Does patient still have >2 criteria despite NIV/HFNC?|==local::at0033|No|"
        ],
        "then": [
          "$gt0036|Comment|='Re-select number of criteria present and follow management.'"
        ]
      },
      "gt0030": {
        "id": "gt0030",
        "priority": 5,
        "when": [
          "$gt0017|Tesing criteria score|>2",
          "$gt0011|Does patient still have >2 criteria despite NIV/HFNC?|==local::at0032|Yes|",
          "$gt0012|Is the intubated patient on CMV?|==local::at0036|No|"
        ],
        "then": [
          "$gt0019|Level|='4'",
          "$gt0020|Management|='Follow ICU protocols; use local ventilator weaning protocol.'",
          "$gt0021|Medications|='Remdesivir (if not available, lopinavir/ritonavir) PLUS considering dexamethasone and tocilizumab.'",
          "$gt0022|Medication consideration|=local::at0007|Consider age/comorbidities, cognitive decline.|",
          "$gt0023|Inclusion criteria for tocilizumab|='First, end of the initial phase of high viral load of COVID-19 (e.g. apyretic from >72h and/or elapsed ≥7 days after the onset of symptoms). Second, worsening of respiratory exchanges, such as to require non-invasive or invasive support from ventilation (Level ≥3). Third, High levels of IL-6 (>40 pg/mL); alternatively high levels of d-dimer, CRP, ferritin, and/or fibrinogen progressively increasing.'"
        ]
      },
      "gt0031": {
        "id": "gt0031",
        "priority": 4,
        "when": [
          "$gt0017|Tesing criteria score|>2",
          "$gt0011|Does patient still have >2 criteria despite NIV/HFNC?|==local::at0032|Yes|",
          "$gt0012|Is the intubated patient on CMV?|==local::at0035|Yes|",
          "$gt0013|PaO2/FiO2 <150 mmHg|==local::at0039|No|"
        ],
        "then": [
          "$gt0019|Level|='5'",
          "$gt0020|Management|='Try to minimize sedation (RASS -1 to 0). Perform SBT daily.'",
          "$gt0021|Medications|='Remdesivir (if not available, lopinavir/ritonavir) PLUS considering dexamethasone and tocilizumab.'",
          "$gt0022|Medication consideration|=local::at0007|Consider age/comorbidities, cognitive decline.|",
          "$gt0023|Inclusion criteria for tocilizumab|='First, end of the initial phase of high viral load of COVID-19 (e.g. apyretic from >72h and/or elapsed ≥7 days after the onset of symptoms). Second, worsening of respiratory exchanges, such as to require non-invasive or invasive support from ventilation (Level ≥3). Third, High levels of IL-6 (>40 pg/mL); alternatively high levels of d-dimer, CRP, ferritin, and/or fibrinogen progressively increasing.'"
        ]
      },
      "gt0032": {
        "id": "gt0032",
        "priority": 3,
        "when": [
          "$gt0017|Tesing criteria score|>2",
          "$gt0012|Is the intubated patient on CMV?|==local::at0035|Yes|",
          "$gt0013|PaO2/FiO2 <150 mmHg|==local::at0038|Yes|",
          "$gt0014|Patient on neuromuscular blockade (NMBA)|==local::at0042|No|",
          "$gt0011|Does patient still have >2 criteria despite NIV/HFNC?|==local::at0032|Yes|"
        ],
        "then": [
          "$gt0019|Level|='6'",
          "$gt0020|Management|='Try to minimize sedation (RASS -1 to 0).'",
          "$gt0021|Medications|='Remdesivir (if not available, lopinavir/ritonavir) PLUS considering dexamethasone and tocilizumab.'",
          "$gt0022|Medication consideration|=local::at0007|Consider age/comorbidities, cognitive decline.|",
          "$gt0023|Inclusion criteria for tocilizumab|='First, end of the initial phase of high viral load of COVID-19 (e.g. apyretic from >72h and/or elapsed ≥7 days after the onset of symptoms). Second, worsening of respiratory exchanges, such as to require non-invasive or invasive support from ventilation (Level ≥3). Third, High levels of IL-6 (>40 pg/mL); alternatively high levels of d-dimer, CRP, ferritin, and/or fibrinogen progressively increasing.'"
        ]
      },
      "gt0033": {
        "id": "gt0033",
        "priority": 2,
        "when": [
          "$gt0017|Tesing criteria score|>2",
          "$gt0012|Is the intubated patient on CMV?|==local::at0035|Yes|",
          "$gt0013|PaO2/FiO2 <150 mmHg|==local::at0038|Yes|",
          "$gt0014|Patient on neuromuscular blockade (NMBA)|==local::at0041|Yes|",
          "$gt0015|Patient prone or on ECMO|==local::at0045|No|",
          "$gt0011|Does patient still have >2 criteria despite NIV/HFNC?|==local::at0032|Yes|"
        ],
        "then": [
          "$gt0019|Level|='7'",
          "$gt0020|Management|='Perform best PEEP and Compliance calculation. Try to suspend NMBA. Optimize volume status.'",
          "$gt0021|Medications|='Remdesivir (if not available, lopinavir/ritonavir) PLUS considering dexamethasone and tocilizumab.'",
          "$gt0022|Medication consideration|=local::at0007|Consider age/comorbidities, cognitive decline.|",
          "$gt0023|Inclusion criteria for tocilizumab|='First, end of the initial phase of high viral load of COVID-19 (e.g. apyretic from >72h and/or elapsed ≥7 days after the onset of symptoms). Second, worsening of respiratory exchanges, such as to require non-invasive or invasive support from ventilation (Level ≥3). Third, High levels of IL-6 (>40 pg/mL); alternatively high levels of d-dimer, CRP, ferritin, and/or fibrinogen progressively increasing.'"
        ]
      },
      "gt0034": {
        "id": "gt0034",
        "priority": 1,
        "when": [
          "$gt0017|Tesing criteria score|>2",
          "$gt0012|Is the intubated patient on CMV?|==local::at0035|Yes|",
          "$gt0013|PaO2/FiO2 <150 mmHg|==local::at0038|Yes|",
          "$gt0014|Patient on neuromuscular blockade (NMBA)|==local::at0041|Yes|",
          "$gt0015|Patient prone or on ECMO|==local::at0044|Yes|",
          "$gt0011|Does patient still have >2 criteria despite NIV/HFNC?|==local::at0032|Yes|"
        ],
        "then": [
          "$gt0019|Level|='8'",
          "$gt0020|Management|='Extreme level of medical complexity given failing other management options; defer to clinician expertise.'",
          "$gt0021|Medications|='Remdesivir (if not available, lopinavir/ritonavir) PLUS considering dexamethasone and tocilizumab.'",
          "$gt0022|Medication consideration|=local::at0007|Consider age/comorbidities, cognitive decline.|",
          "$gt0023|Inclusion criteria for tocilizumab|='First, end of the initial phase of high viral load of COVID-19 (e.g. apyretic from >72h and/or elapsed ≥7 days after the onset of symptoms). Second, worsening of respiratory exchanges, such as to require non-invasive or invasive support from ventilation (Level ≥3). Third, High levels of IL-6 (>40 pg/mL); alternatively high levels of d-dimer, CRP, ferritin, and/or fibrinogen progressively increasing.'"
        ]
      }
    }
  },
  "ontology": {
    "term_definitions": {
      "en": {
        "id": "en",
        "terms": {
          "gt0001": {
            "id": "gt0001",
            "text": "Brescia-COVID Respiratory Severity Scale (BCRSS)/Algorithm",
            "description": "Brescia-COVID Respiratory Severity Scale (BCRSS)/Algorithm is a step-wise approach to managing patients with confirmed/presumed COVID-19 pneumonia. "
          },
          "gt0003": {
            "id": "gt0003",
            "text": "Patient has COVID-19 pneumonia",
            "description": "*"
          },
          "gt0004": {
            "id": "gt0004",
            "text": "COVID-19 symptoms for ≥7 days",
            "description": "*"
          },
          "gt0005": {
            "id": "gt0005",
            "text": "Patient is PCR positive",
            "description": "*"
          },
          "gt0006": {
            "id": "gt0006",
            "text": "High suspicion for COVID-19/PCR pending",
            "description": "*"
          },
          "gt0007": {
            "id": "gt0007",
            "text": "Patient wheezing OR unable to speak in full sentences while at rest/with minimal effort",
            "description": "*"
          },
          "gt0008": {
            "id": "gt0008",
            "text": "Respiratory rate >22",
            "description": "*"
          },
          "gt0009": {
            "id": "gt0009",
            "text": "PaO2 <65 mmHg or SpO2 <90%",
            "description": "*"
          },
          "gt0010": {
            "id": "gt0010",
            "text": "Repeat CXR is significantly worsening",
            "description": "*"
          },
          "gt0011": {
            "id": "gt0011",
            "text": "Does patient still have >2 criteria despite NIV/HFNC?",
            "description": "*"
          },
          "gt0012": {
            "id": "gt0012",
            "text": "Is the intubated patient on CMV?",
            "description": "*"
          },
          "gt0013": {
            "id": "gt0013",
            "text": "PaO2/FiO2 <150 mmHg",
            "description": "*"
          },
          "gt0014": {
            "id": "gt0014",
            "text": "Patient on neuromuscular blockade (NMBA)",
            "description": "*"
          },
          "gt0015": {
            "id": "gt0015",
            "text": "Patient prone or on ECMO",
            "description": "*"
          },
          "gt0017": {
            "id": "gt0017",
            "text": "Tesing criteria score",
            "description": "*"
          },
          "gt0019": {
            "id": "gt0019",
            "text": "Level",
            "description": "*"
          },
          "gt0020": {
            "id": "gt0020",
            "text": "Management",
            "description": "*"
          },
          "gt0021": {
            "id": "gt0021",
            "text": "Medications",
            "description": "*"
          },
          "gt0022": {
            "id": "gt0022",
            "text": "Medication consideration",
            "description": "*"
          },
          "gt0023": {
            "id": "gt0023",
            "text": "Inclusion criteria for tocilizumab",
            "description": "*"
          },
          "gt0024": {
            "id": "gt0024",
            "text": "Set Testing criteria score calculation"
          },
          "gt0025": {
            "id": "gt0025",
            "text": "Set level, management and medication to level 0"
          },
          "gt0026": {
            "id": "gt0026",
            "text": "Set level, management and medication to level 1"
          },
          "gt0027": {
            "id": "gt0027",
            "text": "Set level, management and medication to level 2"
          },
          "gt0028": {
            "id": "gt0028",
            "text": "Set level, management and medication to level 3"
          },
          "gt0030": {
            "id": "gt0030",
            "text": "Set level, management and medication to level 4"
          },
          "gt0031": {
            "id": "gt0031",
            "text": "Set level, management and medication to level 5"
          },
          "gt0032": {
            "id": "gt0032",
            "text": "Set level, management and medication to level 6"
          },
          "gt0033": {
            "id": "gt0033",
            "text": "Set level, management and medication to level 7"
          },
          "gt0034": {
            "id": "gt0034",
            "text": "Set level, management and medication to level 8"
          },
          "gt0035": {
            "id": "gt0035",
            "text": "Set Does patient doesn't have >2 criteria despite NIV/HFNC"
          },
          "gt0036": {
            "id": "gt0036",
            "text": "Comment",
            "description": "*"
          }
        }
      }
    }
  }
}